195 Participants Needed

Group Counseling + Peer Support for Health-Related Stigma

(HEARTS Trial)

RP
Overseen ByRebecca Pearl, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Florida
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. However, if you have recently changed medications for psychiatric reasons, you may not be eligible to participate.

What data supports the effectiveness of the treatment Group Counseling + Peer Support for Health-Related Stigma?

Research shows that group therapy and peer support can help people with mental health conditions like schizophrenia and depression cope with stigma and feel more empowered. This suggests that similar approaches might be effective for other health-related stigmas as well.12345

Is group counseling and peer support safe for participants?

The research does not specifically address safety concerns, but group counseling and peer support interventions are generally considered safe as they focus on reducing stigma and promoting positive attitudes without involving physical risks.678910

How is the Group Counseling + Peer Support treatment for health-related stigma different from other treatments?

This treatment is unique because it combines group counseling with peer support, leveraging personal experiences and relationships to address stigma, which is not commonly emphasized in other treatments. It focuses on building supportive communities and personal connections, which can be particularly effective in reducing stigma and improving mental health.1112131415

What is the purpose of this trial?

Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and peer support, to determine the optimal method for helping patients cope with health-related stigma, reducing its internalization, and enhancing patient quality of life.

Research Team

RP

Rebecca Pearl, PhD

Principal Investigator

University of Florida

Eligibility Criteria

This trial is for adults over 18 with conditions like obesity, skin diseases, cancer (including those in remission), diabetes, or chronic pain who feel stigmatized because of their health. They must recognize this stigma and be able to attend virtual group meetings regularly for 6 months.

Inclusion Criteria

Willingness to actively participate and share information about themselves in the group meetings
I have a device with internet for the study or need one provided.
I have a health condition like obesity, skin disease, cancer, HIV, diabetes, or chronic pain and feel stigmatized because of it.
See 1 more

Exclusion Criteria

No reported internalization of health-related stigma and/or score below pre-specified cutoff on internalized stigma measure
I have recently been in psychotherapy, support groups, or psychiatric care.
I have changed my psychiatric medications in the last 3 months.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive group telehealth sessions for 12 weeks, followed by 2 every-other-week sessions and 2 monthly sessions

26 weeks
16 sessions (virtual)

Follow-up

Participants are monitored for changes in internalized stigma and other outcomes

4 weeks

Waitlist Control Intervention

Waitlist control group receives 12 weeks of the group counseling intervention after completing the week 26 assessment

12 weeks

Treatment Details

Interventions

  • Counseling Intervention
  • Healing HEARTS
  • Peer Support
Trial Overview The study tests a new counseling program called Healing HEARTS alongside peer support. It aims to help patients deal with the shame they might feel about their illness by talking in groups and supporting each other to improve mental health and life quality.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Healing HEARTS InterventionExperimental Treatment1 Intervention
The Healing Health-Related Stigma (Healing HEARTS) intervention will provide group telehealth sessions adapted from prior disease-specific interventions for internalized stigma and from standard techniques and structures used in evidence-based cognitive-behavioral therapies. Fifty-minute sessions will be delivered weekly for 12 weeks, followed by 2 every-other-week and 2 monthly sessions. Groups will consist of approximately 8-10 participants and will be led by a doctoral- or masters-level clinician in clinical or counseling psychology or social work. Handouts and homework assignments will be used as part of the group meetings. All group sessions will be conducted remotely using telehealth technology.
Group II: Peer SupportActive Control1 Intervention
The peer support condition will provide group telehealth sessions without any tailored stigma content. Group sessions will be 50 minutes and will meet weekly for 12 weeks, followed by 2 every-other-week and 2 monthly sessions. Groups will consist of approximately 8-10 participants and will be led by a doctoral- or masters-level clinician in clinical or counseling psychology or social work. All group sessions will be conducted remotely using telehealth technology.
Group III: Waitlist ControlActive Control1 Intervention
The waitlist control group will not receive any active intervention until after completing week 12 and week 26 assessments. Participants will receive periodical updates and reminders from study staff to enhance retention. After assessments are completed, participants will be provided with 12 weeks of the Healing HEARTS intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Findings from Research

Patient education through balanced videos significantly improved attitudes toward medical cannabis, as shown by a notable increase in scores on the Recreational and Medical Cannabis Attitudes Scale (RMCAS) among 111 participants.
This study highlights the effectiveness of health education in reducing stigma associated with medical cannabis, suggesting that future health policies should prioritize educational approaches to improve access to care.
The impact of education on attitudes toward medical cannabis.Clobes, TA., Palmier, LA., Gagnon, M., et al.[2023]
A psycho-educational group therapy module called STEM, designed to help patients with schizophrenia and depression cope with stigma, was tested in a clinical trial involving 462 patients across various mental health settings.
While both the intervention and control groups showed significant improvements in quality of life and empowerment, there was no significant difference in outcomes between the two groups, indicating that the standard therapy alone was effective.
Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT.Gaebel, W., Zäske, H., Hesse, K., et al.[2021]
A systematic review of 42 studies over the past 5 years highlights that stigma in health facilities significantly hinders diagnosis and treatment, emphasizing the need for effective interventions to improve healthcare outcomes.
While there are common approaches to reduce stigma related to HIV, mental illness, and substance abuse, there is a notable lack of interventions targeting other conditions like tuberculosis and cancer, indicating a need for broader strategies that involve both patients and healthcare workers.
Stigma in health facilities: why it matters and how we can change it.Nyblade, L., Stockton, MA., Giger, K., et al.[2023]

References

The impact of education on attitudes toward medical cannabis. [2023]
Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT. [2021]
Stigma in health facilities: why it matters and how we can change it. [2023]
Reducing depression stigma using a web-based program. [2022]
Ending self-stigma: pilot evaluation of a new intervention to reduce internalized stigma among people with mental illnesses. [2022]
Characterizing suicide-related self-disclosure by peer specialists: a qualitative analysis of audio-recorded sessions. [2023]
The effects of group counseling and self-affirmation on stigma and group relationship development: A replication and extension. [2023]
Provider Opinions Regarding the Development of a Stigma-Reduction Intervention Tailored for Providers. [2022]
Changing stigma through a consumer-based stigma reduction program. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
The California Assessment of Stigma Change: A Short Battery to Measure Improvements in the Public Stigma of Mental Illness. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
SafeTalk: Training Peers to Deliver a Motivational Interviewing HIV Prevention Program. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Facilitating support groups for professionals working with people with AIDS. [2007]
Embodied work: insider perspectives on the work of HIV/AIDS peer counselors. [2021]
Evaluation of a peer support group therapy for HIV-infected adolescents. [2019]
'Management of a spoiled identity': systematic review of interventions to address self-stigma among people living with and affected by HIV. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security